A CHS patient improved with topical capsaicin, supporting the TRPV1 receptor theory for why hot showers help
A case report of CHS treated with topical capsaicin proposed that the condition arises from decreased TRPV1 receptor signaling due to chronic cannabis use, explaining why hot water bathing and capsaicin (both TRPV1 activators) provide relief.
Quick Facts
What This Study Found
A patient with cannabinoid hyperemesis syndrome experienced symptom improvement after topical capsaicin application.
The authors proposed a novel mechanistic model: chronic cannabis use decreases signaling through the transient receptor potential vanilloid subtype 1 (TRPV1) receptor, which alters gastric motility and triggers the nausea/vomiting cycle.
This model explains the previously puzzling observation that CHS patients compulsively seek hot baths: both hot water and capsaicin activate TRPV1 receptors, temporarily restoring the signaling that chronic cannabis has dampened.
Previous models focused solely on CB1 receptor derangement, but the TRPV1 model fills gaps in understanding, including why hot bathing provides relief and why the syndrome develops only in some chronic users (who may have different baseline TRPV1 sensitivity).
Key Numbers
Single patient improved with topical capsaicin. TRPV1 receptor is activated by marijuana, capsaicin, and heat. Chronic cannabis use proposed to decrease TRPV1 signaling.
How They Did This
Single case report with a proposed mechanistic model linking TRPV1 receptor downregulation to CHS pathophysiology.
Why This Research Matters
Understanding why capsaicin and hot water work for CHS is not just academic. If the TRPV1 mechanism is correct, it suggests new therapeutic targets and explains individual differences in CHS susceptibility. It also supports capsaicin as a rational (not just empirical) treatment.
The Bigger Picture
The TRPV1 hypothesis provides a unifying explanation for multiple CHS features: the nausea from cannabinoid-induced TRPV1 downregulation, the relief from hot water (TRPV1 activation by heat), and the effectiveness of capsaicin (TRPV1 agonist). This could guide development of more targeted treatments.
What This Study Doesn't Tell Us
Single case report. The TRPV1 mechanism is proposed but not proven. The model does not fully explain why only some chronic cannabis users develop CHS. No controlled comparison to other treatments.
Questions This Raises
- ?Can TRPV1 receptor sensitivity be measured to predict CHS risk?
- ?Would chronic capsaicin use prevent CHS in heavy cannabis users?
- ?Do TRPV1 genetic variants explain individual CHS susceptibility?
Trust & Context
- Key Stat:
- TRPV1 receptor model explains both the CHS mechanism and why hot baths and capsaicin help
- Evidence Grade:
- Preliminary. Single case with a proposed mechanism. The TRPV1 model is plausible but requires experimental validation.
- Study Age:
- Published in 2018. The TRPV1 theory for CHS has gained traction and capsaicin has become an accepted treatment option.
- Original Title:
- Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.
- Published In:
- ACG case reports journal, 5, e3 (2018)
- Authors:
- Moon, Andrew M, Buckley, Sarah A, Mark, Nicholas M
- Database ID:
- RTHC-01768
Evidence Hierarchy
Describes what happened to one person or a small group.
What do these levels mean? →Frequently Asked Questions
What is TRPV1?
TRPV1 (transient receptor potential vanilloid subtype 1) is a receptor that responds to heat, capsaicin (the compound that makes chili peppers hot), and some cannabinoids. It plays roles in pain sensation, temperature regulation, and gastrointestinal motility.
How does capsaicin help CHS?
Capsaicin cream applied to the abdomen activates TRPV1 receptors, the same receptors stimulated by hot water. According to this model, chronic cannabis use downregulates TRPV1, and capsaicin temporarily restores the signaling, relieving nausea and vomiting.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-potency-increase-over-time
- cannabis-harm-reduction-opioids-alcohol-replacement
- cannabis-legalization-effects-health-data
- cannabis-relapse-cycle-pattern
- cannabis-tolerance-break-guide
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-cut-back-on-weed-moderation
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- microdosing-cannabis-benefits
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- safer-cannabis-use-guidelines
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- sober-october-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- tolerance-break-weed
- weed-for-opioid-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-01768APA
Moon, Andrew M; Buckley, Sarah A; Mark, Nicholas M. (2018). Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.. ACG case reports journal, 5, e3. https://doi.org/10.14309/crj.2018.3
MLA
Moon, Andrew M, et al. "Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.." ACG case reports journal, 2018. https://doi.org/10.14309/crj.2018.3
RethinkTHC
RethinkTHC Research Database. "Successful Treatment of Cannabinoid Hyperemesis Syndrome wit..." RTHC-01768. Retrieved from https://rethinkthc.com/research/moon-2018-successful-treatment-of-cannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.